. AD and its comorbidities: An obstacle to develop a clinically efficient treatment?. Rev Neurol (Paris). 2022 May;178(5):450-459. Epub 2022 May 2 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.